TORII PHARMACEUTICAL COTORII PHARMACEUTICAL COTORII PHARMACEUTICAL CO

TORII PHARMACEUTICAL CO

No trades
See on Supercharts

4551 fundamentals

Key facts

Market capitalization
Founded
CEO
Website
About

Torii Pharmaceutical Co., Ltd. engages in the manufacturing and marketing of pharmaceutical products. Its products are mainly used for renal diseases and hemodialysis, human immunodeficiency virus (HIV), skin diseases, and allergies. These include Riona, Remitch, Kayexalate, Corectim, Antebate, Cedarcure, and Miticure. The company was founded by Tokubei Torii in 1872 and is headquartered in Tokyo, Japan.

Valuation

Fundamental metrics to determine fair value of the stock

Summary
No data available
There's currently no market capitalization, revenue or net income data to show.
Valuation ratios

Growth and Profitability

Company’s recent performance and margins

Dividends

Dividend yield, history and sustainability

No dividends
4551 has never paid dividends and has no current plans to do so.

Financial health

Financial position and solvency of the company